Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Oppenheimer analyst Jeff Jones initiated coverage on Odyssey Therapeutics Inc (NASDAQ:ODTX) with an Outperform rating and announced a price target of $40. Odyssey Therapeutics shares closed at $16.96 on Tuesday. See how other analysts view this stock.
- BofA Securities analyst Travis Steed initiated coverage on Mobia Medical Inc (NASDAQ:MOBI) with a Buy rating and announced a price target of $16. Mobia Medical shares closed at $13.50 on Tuesday. See how other analysts view this stock.
- BTIG analyst Ryan Zimmerman initiated coverage on Mobia Medical Inc (NASDAQ:MOBI) with a Buy rating and announced a price target of $19. Mobia Medical shares closed at $13.50 on Tuesday. See how other analysts view this stock.
- Needham analyst Serge Belanger initiated coverage on Veradermics Inc (NASDAQ:MANE) with a Buy rating and announced a price target of $136. Veradermics shares closed at $101.51 on Tuesday. See how other analysts view this stock.
- Goldman Sachs analyst David Roman initiated coverage on Mobia Medical Inc (NASDAQ:MOBI) with a Buy rating and announced a price target of $31. Mobia Medical shares closed at $13.50 on Tuesday. See how other analysts view this stock.
Considering buying MOBI stock? Here’s what analysts think:
Login to comment